av/acelrx-pharmaceuticals--big.svg

NASDAQ:ACRX

AcelRx Pharmaceuticals, Inc.

  • Stock

USD

Last Close

0.80

09/01 21:00

Market Cap

14.58M

Beta: 0.24

Volume Today

241.00K

Avg: 223.92K

PE Ratio

−1.83

PFCF: −0.68

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
29.50M
-
5.22M
82.32%
19.26M
269.24%
17.36M
9.89%
8.00M
53.94%
2.15M
73.10%
2.29M
6.42%
5.42M
136.61%
2.82M
47.97%
1.77M
37.15%
651K
63.24%
cost of revenue
1.77M
-
12.31M
595.76%
10.66M
13.45%
3.98M
62.70%
6.81M
71.18%
6.03M
11.37%
3.75M
37.78%
2.59M
30.96%
gross profit
29.50M
-
5.22M
82.32%
17.49M
235.31%
5.04M
71.18%
-2.66M
152.84%
-1.82M
31.49%
-4.52M
147.51%
-616K
86.36%
-935K
51.79%
-820K
12.30%
651K
179.39%
selling and marketing expenses
1.10M
-
general and administrative expenses
9.88M
-
18.35M
85.74%
14.20M
22.58%
15.60M
9.81%
16.61M
6.49%
20.77M
25.02%
43.93M
111.54%
selling general and administrative expenses
9.88M
-
18.35M
85.74%
14.20M
22.58%
15.60M
9.81%
16.61M
6.49%
20.77M
25.02%
45.03M
116.84%
36.33M
19.32%
30.93M
14.85%
25.67M
17.01%
11.99M
53.28%
research and development expenses
26.29M
-
24.52M
6.74%
22.49M
8.29%
21.40M
4.83%
19.41M
9.31%
13.14M
32.31%
4.66M
64.52%
4.02M
13.82%
4.09M
1.94%
5.19M
26.81%
5.55M
6.80%
other expenses
-15.24M
-
2.53M
-
84.05M
-
cost and expenses
36.17M
-
42.87M
18.52%
38.46M
10.28%
49.31M
28.22%
46.68M
5.35%
37.88M
18.85%
56.49M
49.15%
46.38M
17.90%
38.78M
16.38%
33.46M
13.74%
17.54M
47.57%
operating expenses
36.17M
-
42.87M
18.52%
36.69M
14.41%
37.00M
0.84%
36.02M
2.65%
33.90M
5.87%
49.69M
46.56%
40.35M
18.80%
35.03M
13.18%
30.86M
11.89%
17.54M
43.17%
interest expense
1.52M
-
2.64M
73.85%
5.41M
104.81%
12.15M
124.83%
14.04M
15.51%
12.56M
10.54%
1.20M
90.46%
3.31M
175.88%
2.29M
30.68%
1.15M
49.67%
-134K
111.62%
ebitda
-21.91M
-
-29.85M
36.24%
-15.49M
48.09%
-28.99M
87.09%
-36.43M
25.67%
-34.59M
5.05%
-52.04M
50.45%
-37.07M
28.76%
-30.83M
16.83%
-30.18M
2.10%
-16.89M
44.04%
operating income
-6.67M
-
-37.65M
464.71%
-19.95M
47.00%
-31.96M
60.15%
-38.68M
21.04%
-35.73M
7.64%
-54.20M
51.72%
-40.96M
24.43%
-35.97M
12.20%
-36.63M
1.86%
-16.89M
53.90%
depreciation and amortization
593K
-
866K
46.04%
1.98M
129.10%
2.05M
3.43%
1.74M
15.01%
575K
67.03%
2.17M
276.70%
3.89M
79.73%
5.13M
31.90%
6.45M
25.61%
total other income expenses net
-15.24M
-
4.30M
128.19%
-756K
117.60%
-11.23M
1,385.98%
-13.53M
20.41%
-11.42M
15.58%
968K
108.48%
588K
39.26%
871K
48.13%
84.40M
9,590.13%
6.60M
92.18%
income before tax
-23.43M
-
-33.35M
42.38%
-23.64M
29.12%
-43.19M
82.71%
-52.21M
20.88%
-47.15M
9.70%
-53.24M
12.92%
-40.38M
24.16%
-35.09M
13.08%
47.77M
236.11%
-10.29M
121.54%
income tax expense
-14.32M
-
6.93M
148.44%
760K
89.04%
-34K
104.47%
-701K
1,961.76%
2K
100.29%
3K
50%
4K
33.33%
5K
25%
13K
160%
net income
-23.43M
-
-33.35M
42.38%
-24.40M
26.85%
-43.16M
76.88%
-51.51M
19.35%
-47.15M
8.46%
-53.24M
12.92%
-40.38M
24.16%
-35.10M
13.08%
47.76M
236.06%
-10.29M
121.54%
weighted average shs out
1.99M
-
2.17M
9.37%
2.22M
2.01%
2.27M
2.29%
2.34M
3.34%
2.92M
24.74%
3.96M
35.57%
4.26M
7.67%
5.99M
40.59%
7.39M
23.23%
14.26B
193,035.71%
weighted average shs out dil
1.99M
-
2.22M
11.51%
2.22M
0.33%
2.27M
1.90%
2.34M
3.47%
2.92M
24.58%
3.96M
35.57%
4.26M
7.67%
5.99M
40.59%
7.41M
23.59%
14.26B
192,471.50%
eps
-11.79
-
-15.36
30.28%
-11.02
28.26%
-19.05
72.87%
-21.97
15.33%
-16.14
26.54%
-13.45
16.67%
-9.47
29.59%
-5.86
38.12%
5.73
197.78%
-0.00
100.01%
epsdiluted
-11.79
-
-15.05
27.65%
-10.97
27.11%
-19.05
73.66%
-21.97
15.33%
-16.14
26.54%
-13.45
16.67%
-9.47
29.59%
-5.86
38.12%
5.72
197.61%
-0.00
100.01%

All numbers in USD (except ratios and percentages)